
Pharma Pulse 3/26/25: COVID's Impact on Drug Discovery, Examining Healthcare Spending Across US Counties & more
The latest news for pharma industry insiders.
What drivers impact the differences in expenditures?
As the COVID-19 pandemic moves into an endemic phase, the major impacts on drug research, collaboration, and use of new technologies due to the spread of the virus warrant recognition.
Ever since AstraZeneca Plc shocked investors in October with news its China chief was under investigation, the British pharmaceutical giant has tried to maintain a business-as-usual stance in its second-biggest market.
The use of self-care to address unmet medical needs could transform how vulnerable populations access treatment and knowledge, while reducing the burden on healthcare systems, according to a recently published study by Bayer’s Research Initiative for Self-Care Equity.
Our founder and CEO Peter Ax recently shared valuable insights with Miranda Schmalfuhs from
Have news you want us to share in Pharma Pulse? Reach out to Editor
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.